Teva Pharmaceutical Industries Ltd (TEVA.xnys) is an Israeli multinational pharmaceutical company headquartered in Petah Tikva, the State of Israel. TEVA focuses on developing, producing, and marketing affordable, high-quality generic drugs and specialty pharmaceuticals. Teva Pharmaceutical is currently the eighth-largest pharmaceutical company globally. Teva Pharmaceutical Industries Ltd employs more than 40,200 professionals in its facilities in Israel and across four continents. In its over 120 years of experience, the Israeli pharmaceutical pioneer has developed a product portfolio of more than 1,800 molecules and 510 drugs. Teva Pharmaceutical Industries Ltd (TEVA.xnys) is traded on the Tel Aviv Stock Exchange (TASE), on the New York Stock Exchange, has a $35.19B (USD) market cap and $16.89B (USD) yearly revenue. Despite TEVA’s long history of fraudulent marketing, price-fixing, and price manipulation, mainly in the United States market, the company’s share price (TEVA.xnys) has increased by 2.87% in value since last year.
Teva Pharmaceutical-Sp Adr (TEVA)
Get Teva Pharmaceutical-Sp Adr (TEVA) share price insights and trends to guide your trading strategy. Stay updated with FP Markets Ecuador.